Functional outcome and mortality following antithrombotic associated intracerebral hemorrhage
Antithrombotic treatments, including antiplatelet (AP), oral anticoagulant (OAC) and thrombolytic drugs, increase the risk of intracerebral hemorrhage (ICH). In the event of an ICH, many suggest that prior use of antithrombotics lead to hematoma expansion, resulting in increased mortality. The relationship between antithrombotic use and increased functional dependency and mortality following ICH is studied in this article and compared to nonantithrombotic associated ICH. Studies have previously shown ambiguous results concerning antithrombotic drugs as independent predictors of functional status and mortality outcome following ICH. The incidence of ICH (ICD.10 i61) in Sweden between 2012-2017 is also analysed in this study.
|Gällande start-/slutdatum||2018/11/26 → …|